Dubious Research from California
Monday, April 26, 2021
After failing to pass the Phase 1 clinical trial, researchers continue to work on the Nusantara vaccine pioneered by Terawan Agus Putranto, but under a new arrangement. The Indonesian Military is said to be divided in its stance on the polemic over the vaccine. In the United States, this research is also said to be problematic. Tempo investigation found that some of the claims made by Aivita, the company that developed the dendritic cell method, did not match reality.
arsip tempo : 173484602470.
THE cellular phone of Coordinating Minister for Human Development and Culture Muhadjir Effendy rang on Friday, April 16. The caller was Minister/State Secretary Pratikno, conveying the news that President Joko Widodo had asked Muhadjir to quickly resolve the polemic over the Nusantara vaccine. Muhadjir promised that the matter could be taken care of in three days.
During that time, Muhadjir contacted the Indonesian Military (TNI) Army Chief of St
...
Subscribe to continue reading.
We craft news with stories.
For the benefits of subscribing to Digital Tempo, See More
